| Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer (NCT00675259) | Ohio State University Comprehensive Cancer Center | 2008-07-01 |
| Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer (NCT00726180) | University of Michigan Rogel Cancer Center | 2008-07-01 |
| Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors (NCT00722228) | Hadassah Medical Organization | 2008-07-01 |
| Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer (NCT00903305) | City of Hope Medical Center | 2008-07-01 |
| Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery (NCT00855114) | Masonic Cancer Center, University of Minnesota | 2008-07-01 |
| Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment (NCT00672217) | University of Colorado, Denver | 2008-07-01 |
| Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer (NCT00721630) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| Screening in Myocardial Perfusion Patients (NCT00943241) | Mayo Clinic | 2008-07-01 |
| A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer (NCT00732056) | Geron Corporation | 2008-07-01 |
| The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy (NCT00727948) | University of Vermont | 2008-07-01 |
| Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy (NCT00722072) | OHSU Knight Cancer Institute | 2008-07-01 |
| Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. (NCT00711529) | Women and Infants Hospital of Rhode Island | 2008-07-01 |
| Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer (NCT00738777) | The Netherlands Cancer Institute | 2008-07-01 |
| Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer (NCT00739063) | M.D. Anderson Cancer Center | 2008-07-01 |
| Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers (NCT00935233) | Queen Mary University of London | 2008-07-01 |
| Lapatinib Resistance in Patients With Breast Cancer (NCT00898573) | Case Comprehensive Cancer Center | 2008-07-01 |
| Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344 (NCT00897026) | Alliance for Clinical Trials in Oncology | 2008-07-01 |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen (NCT00764322) | UNC Lineberger Comprehensive Cancer Center | 2008-06-18 |
| Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer (NCT00897845) | ECOG-ACRIN Cancer Research Group | 2008-06-17 |
| Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (NCT00676663) | Syndax Pharmaceuticals | 2008-06-13 |
| Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors (NCT00738998) | M.D. Anderson Cancer Center | 2008-06-05 |
| Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer (NCT00670878) | Ludwig-Maximilians - University of Munich | 2008-06-01 |
| Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer (NCT00933088) | NYU Langone Health | 2008-06-01 |
| Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy (NCT00699101) | SenoRx, Inc. | 2008-06-01 |
| Cone Beam Computed Tomography for Breast Imaging (NCT00972413) | Koning Corporation | 2008-06-01 |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer (NCT00674557) | Cancer Research UK | 2008-06-01 |
| Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy (NCT01314963) | Stanford University | 2008-06-01 |
| Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes (NCT00805597) | Chinese Academy of Medical Sciences | 2008-06-01 |
| Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer (NCT00688337) | Tel-Aviv Sourasky Medical Center | 2008-06-01 |
| A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer (NCT00793962) | Chinese Academy of Medical Sciences | 2008-06-01 |
| Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety (NCT00712569) | Memorial Sloan Kettering Cancer Center | 2008-06-01 |
| A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer (NCT00754312) | Syndax Pharmaceuticals | 2008-06-01 |
| Comparing Local Anesthesia With General Anesthesia for Breast Cancer Surgery (NCT00938171) | Mackay Memorial Hospital | 2008-06-01 |
| Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients (NCT01131364) | Philogen S.p.A. | 2008-06-01 |
| Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients (NCT01361035) | Tulane University School of Medicine | 2008-06-01 |
| Upper Extremity Lymphatic Mapping for Breast Cancer Patients (NCT00717886) | Memorial Sloan Kettering Cancer Center | 2008-06-01 |
| Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab (NCT00875238) | Vanderbilt University | 2008-06-01 |
| Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer (NCT00704158) | CuraGen Corporation | 2008-06-01 |
| A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue (NCT00727662) | National Center for Complementary and Integrative Health (NCCIH) | 2008-06-01 |
| White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors (NCT00709020) | City of Hope Medical Center | 2008-06-01 |
| Pregabalin in Treating Women With Hot Flashes (NCT00702949) | Alliance for Clinical Trials in Oncology | 2008-06-01 |
| Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer (NCT00692289) | AstraZeneca | 2008-06-01 |
| Stereotactic Directional Vacuum-Assisted Breast Biopsy (NCT01957020) | National Taiwan University Hospital | 2008-06-01 |
| Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors (NCT00704392) | Exelixis | 2008-06-01 |
| An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO) (NCT00726661) | Genentech, Inc. | 2008-06-01 |
| Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm (NCT00776724) | National Taiwan University Hospital | 2008-05-29 |
| AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer (NCT01445418) | National Cancer Institute (NCI) | 2008-05-12 |
| Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer (NCT00660803) | AstraZeneca | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer (NCT00677326) | Tokyo University | 2008-05-01 |
| Expanding Rural Access: Distance Delivery of Support Groups (Main Study) (NCT01108016) | Stanford University | 2008-05-01 |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer (NCT00742222) | Xoft, Inc. | 2008-05-01 |
| Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer (NCT00680758) | Vanderbilt-Ingram Cancer Center | 2008-05-01 |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer (NCT00673829) | Roger Williams Medical Center | 2008-05-01 |
| Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy (NCT00688194) | Gruppo Italiano Mammella (GIM) | 2008-05-01 |
| Quantitative Analysis of Outcomes in Breast Reconstruction (NCT00677430) | M.D. Anderson Cancer Center | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer (NCT00678509) | Tokyo University | 2008-05-01 |
| Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer (NCT01614184) | University of Utah | 2008-05-01 |
| Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR) (NCT00679874) | University of Calgary | 2008-05-01 |
| Safety Study of Modified Vaccinia Virus to Cancer (NCT00574977) | David Bartlett | 2008-05-01 |
| Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00687648) | National Cancer Centre, Singapore | 2008-05-01 |
| Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer (NCT00899639) | Rutgers, The State University of New Jersey | 2008-05-01 |
| Use of the Contura™ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients (NCT00882596) | Cancer Center of Irvine | 2008-05-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Collect Breast Cancer Patients' Digital Mammography Images With Corresponding Reports for the Development of Software (NCT00749255) | WellSpan Health | 2008-05-01 |
| Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer (NCT00879489) | Quantum Immunologics, Inc. | 2008-05-01 |
| Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer (NCT00705315) | Hellenic Oncology Research Group | 2008-05-01 |
| Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) (NCT00708903) | Puma Biotechnology, Inc. | 2008-05-01 |
| Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study (NCT00653718) | Centre hospitalier de l'Université de Montréal (CHUM) | 2008-05-01 |
| CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach) (NCT00681122) | AstraZeneca | 2008-05-01 |
| LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients (NCT00632489) | SCRI Development Innovations, LLC | 2008-05-01 |
| Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer (NCT00616967) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-05-01 |
| Lapatinib and Trastuzumab With or Without Endocrine Therapy (NCT00548184) | Baylor Breast Care Center | 2008-05-01 |
| Detection of Aggressive Breast Tumors Using Tc-99m-NC100692 (NCT00888589) | Michael O'Connor | 2008-05-01 |
| Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (NCT00673335) | UNICANCER | 2008-05-01 |
| Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer (NCT00670982) | Harold J. Burstein, MD, PhD | 2008-05-01 |
| Adjuvant AI Combined With Zoladex (NCT01352091) | Fudan University | 2008-05-01 |
| Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer (NCT00641303) | University of Maryland, Baltimore | 2008-05-01 |
| Efficacy of Tomosynthesis in the BIRADS 3 Population (NCT00763100) | WellSpan Health | 2008-05-01 |
| Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer (NCT00706030) | Puma Biotechnology, Inc. | 2008-04-29 |
| Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer (NCT00622466) | University of Texas Southwestern Medical Center | 2008-04-23 |
| Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema (NCT00828516) | East and North Hertfordshire NHS Trust | 2008-04-01 |
| Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) (NCT00503750) | Emory University | 2008-04-01 |
| Development of a Clinical Trial Specific Question Prompt List (NCT00662324) | Memorial Sloan Kettering Cancer Center | 2008-04-01 |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients (NCT00859768) | Netherlands Open University | 2008-04-01 |
| Development of Vitamin D as a Therapy for Breast Cancer - Phase 2 (NCT00656019) | Stanford University | 2008-04-01 |
| Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers (NCT00897455) | Gynecologic Oncology Group | 2008-04-01 |
| Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects (NCT00777530) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer (NCT00702858) | Legacy Health System | 2008-04-01 |
| A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer (NCT00627627) | MedImmune LLC | 2008-04-01 |
| Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma (NCT00671918) | Navidea Biopharmaceuticals | 2008-04-01 |
| BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab (NCT00625898) | NSABP Foundation Inc | 2008-04-01 |
| Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy (NCT00661531) | Georgetown University | 2008-04-01 |
| Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer (NCT00656669) | Indiana University | 2008-04-01 |
| Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure (NCT00570921) | Mara Chambers | 2008-04-01 |
| Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer (NCT00794989) | Roswell Park Cancer Institute | 2008-04-01 |
| APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) (NCT00657137) | Tragara Pharmaceuticals, Inc. | 2008-04-01 |
| Laser Spectroscopy of Breast Tissue Through a Needle Device (NCT00918788) | Case Comprehensive Cancer Center | 2008-04-01 |
| Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery (NCT00674414) | UNICANCER | 2008-04-01 |
| Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer (NCT00629499) | SCRI Development Innovations, LLC | 2008-04-01 |
| Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer (NCT00691379) | Hellenic Oncology Research Group | 2008-04-01 |